Yantai Projiji Pharmaceutical expands recombinant human albumin capacity

Yantai Projimed Pharmaceutical Technology Co., Ltd. announced an expansion project for recombinant human albumin production in Yantai, Shandong. The 1 billion yuan investment will add production lines, increasing annual capacity to 1.7 million vials.

“Total Project Investment 100000 Ten thousand yuan, industry category is C2761 Biopharmaceutical manufacturing.”en.protgen.com

• 1 source
• en.protgen.comEnvironmental Impact Assessment First Public Information Release: Expansion Project for Recombinant Human Albumin, Yantai Projiji Pharmaceutical Technology Co., Ltd.-Progen Protein Technology National Engineering Research CenterApr 28, 2025

Summarized from public sources; check the original articles before acting on it.